Stocks · Health care · Biological Products, (No Diagnostic Substances)

Neumora Therapeutics, Inc.

NMRA Clue Score21
United States Fiscal year ends December CIK 0001885522 Results filed 14 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Michael Lee Milligan
17 Feb 2026
See Remarks
Sold on a plan
1,436
$3.57
$5.12K
Daljit Singh Aurora
11 Nov 2025
See Remarks
Sold on a plan indirect
114,703
$2.68
$307.03K

What was left out

Form 4 filings counted 21
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 11
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 419,813
History held since 18 Sep 2023